:
| Printer FriendlyClick to print this page | Add to Favorites Click to add to favorites| Font Size 

DOD Medical Materiel Quality Control Messages (MMQC)/Medical Materiel Information Messages (MMI) & Images

Army Seal Air Force Seal Navy Seal Marine Corp Seal DOD Seal
MMI-14-4001

Medical Material Information Message

MMI-14-4001


Message Number: MMI-14-4001
Released On: 31-JAN-14
Message Class: Unclassified
Material Type: Vaccine
MMQC\MMI Reference:
FDA Recall Reference:
ECRI Reference:
DLA Reference:
MFG Release Date:

Subject:

2014 - 2015 INFLUENZA VIRUS VACCINE - CALL FOR REQUIREMENTS / SUSPENSE: 28 FEBRUARY 2014



Reason / Information:

ARMY ONLY MESSAGE. AIR FORCE / NAVY THIS INFORMATION DOES NOT APPLY.

Purpose of this message is to call for requirements for 2014-2015 Influenza (FLU) Vaccine. All Active and Reserve Component Installations should plan for 100% mandatory vaccination of service members as a total force vaccination is expected.

Request Command/Activity coordinate with the Preventive Medicine Staff, Pharmacy Officers, Logisticians, as well as last year's Influenza Point of Contacts (POC's) to determine the number of DOSES needed for your requirements. Review deployment and redeployment schedules.

By using the age categories, provide your requirements via e-mail to: usarmy.detrick.medcom-usamma.mbx.vaccines@mail.mil; or teresa.e.bess.civ@mail.mil. If email is unavailable, fax this information to: 301-619-4468 or DSN 343-4468, NLT 28 February 2014.


Disposition / Instructions:

To obtain the DoD Influenza Vaccine Ordering Guide - See Image on Message (Under Additional Documentation/Attachments).

NOTE: Category H - High Risk Conditions Include:

- Persons with a history of hypersensitivity, including anaphylaxis, to any of the components of Live Attenuated Influenza Vaccine (LAIV) or to eggs;
- Persons with any of the underlying medical conditions that serve as an indication for routine influenza vaccination, including asthma, reactive airways disease, or other chronic disorders of the pulmonary or cardiovascular systems;
- Other underlying medical conditions, including such metabolic diseases as diabetes, renal dysfunction, and hemoglobinopathies; or known or suspected immunodeficiency diseases or immunosuppressed states;
- Children or adolescents receiving aspirin or other salicylates (because of the association of Reye Syndrome with wild-type influenza virus infection);
- Persons with a history of Guillain-Barre Syndrome; or
- Pregnant Women.

Information to Consider:

- Check state law regarding use of vaccines with Thimerosal before ordering. In Accordance With (IAW) Health Affairs (HA) Policy 08-013, DoD guidance regarding Thimerosal containing vaccines is as follows: In an effort to comply with local requirements, facilities providing immunization services should make every attempt to comply with state law related to vaccines preserved with Thimerosal. If Thimerosal-Free Vaccines are not available in local communities that require them, do not withhold immunization, but obtain patient's consent for immunization. Available at (http://www.health.mil/libraries/HA_Policies_and_Guidelines/08-013.pdf)

- Current Advisory Committee on Immunization Practices (ACIP) influenza guidelines state that children aged 6 months through 8 years require 2 doses of influenza vaccine (administered a minimum of 4 weeks apart) during their first season of vaccination to optimize immune response. Additional information is available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6207a1.htm.

- IAW HA policy 08-005: Civilian health care personnel who provide direct patient care in DoD medical treatment facilities are required to be immunized against seasonal influenza infection each year as a condition of employment, unless there is documented medical or religious exemption. http://www.vaccines.mil/documents/1169HCPFluHAPolicy_08_005.pdf

Estimated delivery schedule for Injectable Vaccine (subject to change):

Aug - 70%
Sep - 30%

Estimated delivery schedule for Nasal Spray Vaccine (subject to change):

Aug - 50%
Sep - 30%
Oct - 20%

Do not offset projected requirements with any on-hand stock of 2013-2014 vaccine. Do not include Army National Guard unit requirements unless you advise the Army service POC below.


Service/Additional Instructions:


POC Contact Information:

US ARMY:
Email: usarmy.detrick.medcom-usamma.mbx.doc@mail.mil
Phone (COMM): 301-619-4300
Phone (DSN): 343-4300
Fax: 301-619-4468

USAMMC-E:
Email: USAMMCE_QA@AMEDD.ARMY.MIL
Phone (COMM): 011-49-6331-86-7118/7181
Phone (DSN): 495-7118
Fax: 6218

USFK CUST CONTACT USAMMC-K PHARM:
Email: USAMMCKCUSTSUPPORT@AMEDD.ARMY.MIL
Phone (COMM): 011-82-54-970-8340
Phone (DSN):
Fax: KOREAN CELL:010-9232-8824


Additional Message Recipients:

Please ensure dissemination of this information to the following:

Command Channels
Immunization Clinics
Medical Log Officers
Medical Staff
Pharmacy Officers
Supply Officers
Supported Activities/Centers
Vaccince Shot Teams


Message Dissemination Authorization

See Army Regulation (Ar) 40-61, 28 January 2005, Chapter 4, And The Department Of The Army Supply Bulletin (Sb 8-75-11) For Applicable Policies And Procedures.


Additional Documentation / Attachments

MMI-14-4001_1.pdf


*** END OF MESSAGE ***
Last Modified Date: 05/23/2014